Rezolute, Inc. (RZLT)
4.22
+0.05
(+1.20%)
USD |
NASDAQ |
Sep 11, 16:00
4.21
-0.01
(-0.24%)
After-Hours: 20:00
Rezolute Price to Book Value : 3.478 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 3.478 |
| September 10, 2026 | 3.437 |
| September 09, 2026 | 3.346 |
| September 08, 2026 | 3.626 |
| September 04, 2026 | 3.775 |
| September 03, 2026 | 3.742 |
| September 02, 2026 | 3.758 |
| September 01, 2026 | 3.709 |
| August 31, 2026 | 3.865 |
| August 28, 2026 | 3.808 |
| August 27, 2026 | 4.104 |
| August 26, 2026 | 4.154 |
| August 25, 2026 | 4.129 |
| August 24, 2026 | 4.129 |
| August 21, 2026 | 4.195 |
| August 20, 2026 | 3.841 |
| August 19, 2026 | 3.890 |
| August 18, 2026 | 3.841 |
| August 17, 2026 | 3.857 |
| August 14, 2026 | 3.791 |
| August 13, 2026 | 3.791 |
| August 12, 2026 | 3.874 |
| August 11, 2026 | 3.808 |
| August 10, 2026 | 3.857 |
| August 07, 2026 | 3.865 |
| Date | Value |
|---|---|
| August 06, 2026 | 3.874 |
| August 05, 2026 | 3.857 |
| August 04, 2026 | 4.096 |
| August 03, 2026 | 4.047 |
| July 31, 2026 | 3.890 |
| July 30, 2026 | 4.022 |
| July 29, 2026 | 3.874 |
| July 28, 2026 | 4.055 |
| July 27, 2026 | 4.071 |
| July 24, 2026 | 4.113 |
| July 23, 2026 | 4.376 |
| July 22, 2026 | 4.121 |
| July 21, 2026 | 4.195 |
| July 20, 2026 | 3.668 |
| July 17, 2026 | 3.800 |
| July 16, 2026 | 3.602 |
| July 15, 2026 | 3.907 |
| July 14, 2026 | 3.981 |
| July 13, 2026 | 3.907 |
| July 10, 2026 | 3.915 |
| July 09, 2026 | 4.228 |
| July 08, 2026 | 4.088 |
| July 07, 2026 | 4.096 |
| July 06, 2026 | 4.063 |
| July 02, 2026 | 4.047 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| SELLAS Life Sciences Group, Inc. | 16.93 |
| AbbVie, Inc. | -- |
| Marker Therapeutics, Inc. | 1.576 |
| Avalo Therapeutics, Inc. | 1.901 |
| Krystal Biotech, Inc. | 7.556 |
Price to Book Value Related Metrics
| Price | 4.22 |
| Earnings Yield | -19.17% |
| Market Cap | 406.35M |